Data-Driven Approach Predicts Daily CDI Risk
|
By HospiMedica International staff writers Posted on 05 Mar 2018 |
|
A novel machine-learning algorithm can estimate a patient's daily risk of developing Clostridium difficile infection (CDI) from electronic health record (EHR) data.
Researchers at Massachusetts General Hospital (MGH; Boston, USA), the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), and other institutions conducted a study that utilized EHR data from 115,958 adult admitted to MGH and the University of Michigan Health System (UM; Ann Arbor, MI, USA), in order to develop a generalizable machine learning algorithm that can identify hospital-specific risk-stratification models.
To do so, the researchers extracted patient demographics, admission details, patient history, and daily hospitalization details. They then developed a machine learning process to help predict a patient's risk of developing CDI by repeatedly analyzing the data. The machine learning process extracted features that could point to constellations of symptoms, circumstances, and details of medical history most likely to result in CDI at any point in the hospital stay. The algorithm identified a total of 2,964 and 4,739 features in the MGH and UM models, respectively.
The MGH and UM models identified different sets of features that could predict the relative importance of risk factors, which varied significantly across hospitals. In particular, in-hospital locations appeared in the set of top risk factors at one hospital, and in the set of protective factors at the other. On average, both models were able to predict CDI five days in advance of clinical diagnosis, using risk stratification models tailored to an institution’s EHR system and patient population. The study was presented at the annual IDWeek meeting, held during October 2017, in San Diego (CA, USA).
“The records contained over 4,000 distinct variables. We have data pertaining to everything from lab results to what bed they are in, to who is in the bed next to them and whether they are infected. We included all medications, labs and diagnoses. And we extracted this on a daily basis,” said senior author Jenna Wiens, PhD, of the University of Michigan. “You can imagine, as the patient moves around the hospital, risk evolves over time, and we wanted to capture that.”
CDI is a serious illness resulting from infection of the internal lining of the colon by C. difficile bacteria, and typically develops after the use of broad-spectrum antibiotics that disrupt normal bowel flora, allowing the bacteria to flourish. The risk of CDI is particularly high in patients aged 65 years and older, and disease recurrence occurs in up to 25% of patients within 30 days of initial treatment. It is the leading cause of nosocomial diarrhea in industrialized countries.
Related Links:
Massachusetts General Hospital
Massachusetts Institute of Technology
University of Michigan Health System
Researchers at Massachusetts General Hospital (MGH; Boston, USA), the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), and other institutions conducted a study that utilized EHR data from 115,958 adult admitted to MGH and the University of Michigan Health System (UM; Ann Arbor, MI, USA), in order to develop a generalizable machine learning algorithm that can identify hospital-specific risk-stratification models.
To do so, the researchers extracted patient demographics, admission details, patient history, and daily hospitalization details. They then developed a machine learning process to help predict a patient's risk of developing CDI by repeatedly analyzing the data. The machine learning process extracted features that could point to constellations of symptoms, circumstances, and details of medical history most likely to result in CDI at any point in the hospital stay. The algorithm identified a total of 2,964 and 4,739 features in the MGH and UM models, respectively.
The MGH and UM models identified different sets of features that could predict the relative importance of risk factors, which varied significantly across hospitals. In particular, in-hospital locations appeared in the set of top risk factors at one hospital, and in the set of protective factors at the other. On average, both models were able to predict CDI five days in advance of clinical diagnosis, using risk stratification models tailored to an institution’s EHR system and patient population. The study was presented at the annual IDWeek meeting, held during October 2017, in San Diego (CA, USA).
“The records contained over 4,000 distinct variables. We have data pertaining to everything from lab results to what bed they are in, to who is in the bed next to them and whether they are infected. We included all medications, labs and diagnoses. And we extracted this on a daily basis,” said senior author Jenna Wiens, PhD, of the University of Michigan. “You can imagine, as the patient moves around the hospital, risk evolves over time, and we wanted to capture that.”
CDI is a serious illness resulting from infection of the internal lining of the colon by C. difficile bacteria, and typically develops after the use of broad-spectrum antibiotics that disrupt normal bowel flora, allowing the bacteria to flourish. The risk of CDI is particularly high in patients aged 65 years and older, and disease recurrence occurs in up to 25% of patients within 30 days of initial treatment. It is the leading cause of nosocomial diarrhea in industrialized countries.
Related Links:
Massachusetts General Hospital
Massachusetts Institute of Technology
University of Michigan Health System
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Immobilization System
Cranial 4Pi Immobilization
New
Medical Adhesive
MED 5570U
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
